Global Biopharmaceuticals Contract Manufacturing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Biopharmaceuticals Contract Manufacturing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Contract manufacturing organization is a company that serve other companies in the biopharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing.
Biopharmaceuticals Contract Manufacturing report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Biopharmaceuticals Contract Manufacturing market is projected to reach US$ 120590 million in 2034, increasing from US$ 87830 million in 2022, with the CAGR of 4.7% during the period of 2024 to 2034. Demand from Process Development and Packaging are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Biopharmaceuticals Contract Manufacturing industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Biopharmaceuticals Contract Manufacturing key companies include Boehringer Ingelheim, Lonza Group AG, Inno Biologics Sdn Bhd, Rentschler Biopharma, JRS Pharma, AGC Biologics, ProBioGen, FUJIFILM Diosynth Biotechnologies and Toyobo Co., Ltd., etc. Boehringer Ingelheim, Lonza Group AG, Inno Biologics Sdn Bhd are top 3 players and held % share in total in 2022.
Biopharmaceuticals Contract Manufacturing can be divided into Biologics and Biosimilars, etc. Biologics is the mainstream product in the market, accounting for % share globally in 2022.
Biopharmaceuticals Contract Manufacturing is widely used in various fields, such as Process Development, Packaging and Others,, etc. Process Development provides greatest supports to the Biopharmaceuticals Contract Manufacturing industry development. In 2022, global % share of Biopharmaceuticals Contract Manufacturing went into Process Development filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Biopharmaceuticals Contract Manufacturing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Boehringer Ingelheim
Lonza Group AG
Inno Biologics Sdn Bhd
Rentschler Biopharma
JRS Pharma
AGC Biologics
ProBioGen
FUJIFILM Diosynth Biotechnologies
Toyobo Co., Ltd.
Samsung Biologics
Thermo Fisher Scientific
Binex Co., Ltd.
WuXi Biologics
AbbVie, Inc.
Segment by Type
Biologics
Biosimilars
Process Development
Packaging
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Biopharmaceuticals Contract Manufacturing market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Biopharmaceuticals Contract Manufacturing introduction, etc. Biopharmaceuticals Contract Manufacturing Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Biopharmaceuticals Contract Manufacturing market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Biopharmaceuticals Contract Manufacturing report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Biopharmaceuticals Contract Manufacturing market is projected to reach US$ 120590 million in 2034, increasing from US$ 87830 million in 2022, with the CAGR of 4.7% during the period of 2024 to 2034. Demand from Process Development and Packaging are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Biopharmaceuticals Contract Manufacturing industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Biopharmaceuticals Contract Manufacturing key companies include Boehringer Ingelheim, Lonza Group AG, Inno Biologics Sdn Bhd, Rentschler Biopharma, JRS Pharma, AGC Biologics, ProBioGen, FUJIFILM Diosynth Biotechnologies and Toyobo Co., Ltd., etc. Boehringer Ingelheim, Lonza Group AG, Inno Biologics Sdn Bhd are top 3 players and held % share in total in 2022.
Biopharmaceuticals Contract Manufacturing can be divided into Biologics and Biosimilars, etc. Biologics is the mainstream product in the market, accounting for % share globally in 2022.
Biopharmaceuticals Contract Manufacturing is widely used in various fields, such as Process Development, Packaging and Others,, etc. Process Development provides greatest supports to the Biopharmaceuticals Contract Manufacturing industry development. In 2022, global % share of Biopharmaceuticals Contract Manufacturing went into Process Development filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Biopharmaceuticals Contract Manufacturing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Boehringer Ingelheim
Lonza Group AG
Inno Biologics Sdn Bhd
Rentschler Biopharma
JRS Pharma
AGC Biologics
ProBioGen
FUJIFILM Diosynth Biotechnologies
Toyobo Co., Ltd.
Samsung Biologics
Thermo Fisher Scientific
Binex Co., Ltd.
WuXi Biologics
AbbVie, Inc.
Segment by Type
Biologics
Biosimilars
Segment by Application
Process Development
Packaging
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Biopharmaceuticals Contract Manufacturing market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Biopharmaceuticals Contract Manufacturing introduction, etc. Biopharmaceuticals Contract Manufacturing Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Biopharmaceuticals Contract Manufacturing market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices